Tu1459 – A Pain in the Gut: A Rare Case Series of Siblings with Lipoprotein Lipase Deficiency and Associated Acute Pancreatitis

2019 ◽  
Vol 156 (6) ◽  
pp. S-1046-S-1047
Author(s):  
Rekha Reddy ◽  
Savanna Thor
Author(s):  
Sarah W Y Poon ◽  
Karen K Y Leung ◽  
Joanna Y L Tung

Summary Severe hypertriglyceridemia is an endocrine emergency and is associated with acute pancreatitis and hyperviscosity syndrome. We describe an infant with lipoprotein lipase deficiency with severe hypertriglyceridemia who presented with acute pancreatitis. She was managed acutely with fasting and intravenous insulin infusion, followed by low-fat diet with no pharmacological agent. Subsequent follow-up until the age of 5 years showed satisfactory lipid profile and she has normal growth and development. Learning points: Hypertriglyceridemia-induced acute pancreatitis has significant morbidity and mortality, and prompt treatment is imperative. When no secondary causes are readily identified, genetic evaluation should be pursued in hypertriglyceridemia in children. Intravenous insulin is a safe and effective acute treatment for hypertriglyceridemia in children, even in infants. Long-term management with dietary modifications alone could be effective for primary hypertriglyceridemia due to lipoprotein lipase deficiency, at least in early childhood phase.


2016 ◽  
Author(s):  
Inmaculada Gonzalez-Molero ◽  
Victoria Contreras Bolivar ◽  
Monserrat Gonzalo MArin ◽  
Gabriel Olveira ◽  
Marta Dominguez ◽  
...  

2012 ◽  
Vol 142 (5) ◽  
pp. S-112 ◽  
Author(s):  
Marco J. Bruno ◽  
Mark Deakin ◽  
Philippe B. Ruszniewski ◽  
Nick V. Bulk ◽  
Janneke de Wal ◽  
...  

2021 ◽  
Vol 13 (1) ◽  
pp. 98-103
Author(s):  
Agnieszka Pawłowska-Kamieniak ◽  
Paulina Krawiec ◽  
Elżbieta Pac-Kożuchowska

Acute pancreatitis (AP) appears to be rare disease in childhood. In children, it has a different aetiology and course, and requires different management than in adult patients. The diagnosis of AP is based on at least two of the three criteria, which include typical clinical symptoms, abnormalities in laboratory tests and/or imaging studies of the pancreas. There are many known causes leading to AP in children including infections, blunt abdominal trauma, genetic factors, gallstone disease, metabolic disorders, anatomical defects of the pancreas, systemic diseases, as well as drugs, including antiepileptic drugs, and especially preparations of valproic acid. In our study, we present four cases of young patients diagnosed with acute pancreatitis as a complication of valproic acid therapy and we present a review of the literature. We believe that the activity of pancreatic enzymes should be monitored in children treated with valproate preparations in the case of clinical symptoms suggesting AP.


1992 ◽  
Vol 33 (5) ◽  
pp. 745-754
Author(s):  
K Ishimura-Oka ◽  
CF Semenkovich ◽  
F Faustinella ◽  
IJ Goldberg ◽  
N Shachter ◽  
...  

2021 ◽  
Vol 88 (2) ◽  
pp. 111-112
Author(s):  
Kshitija Patil ◽  
Neerja Gupta

Dose-Response ◽  
2020 ◽  
Vol 18 (1) ◽  
pp. 155932582090235
Author(s):  
Shih-Wei Lai ◽  
Cheng-Chan Yu ◽  
Cheng-Li Lin ◽  
Kuan-Fu Liao

Background/Objective: Some case series and case report have shown the association between the risk of acute pancreatitis and use of selective serotonin reuptake inhibitors. The results of systematic studies were not consistent. Methods: A meta-analysis was performed to investigate the risk of acute pancreatitis associated with use of selective serotonin reuptake inhibitors. Results: There was no statistical association between the risk of acute pancreatitis and selective serotonin reuptake inhibitors use (odds ratio: 1.19, 95% confidence interval: 0.93-1.51). Conclusions: Despite reaching no statistical significance, the possibility of the association between the risk of acute pancreatitis and selective serotonin reuptake inhibitors use cannot be totally excluded.


Sign in / Sign up

Export Citation Format

Share Document